2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
CNS
1
Conditions
Febrile Neutropenia
6
Neutropenia
5
Neoplasms
4
Infections
4
Fever
4
Colorectal Neoplasms
3
Carcinoma, Hepatocellular
3
Melanoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Hematologic Neoplasms
2
Waldenstrom Macroglobulinemia
1
Urinary Tract Infections
1
Stomach Neoplasms
1
Staphylococcal Infections
1
Spasm
1
Sleep Initiation and Maintenance Disorders
1
Sepsis
1
Seizures
1
Schizophrenia, Treatment-Resistant
1
Schizophrenia
1
Retinitis
1
Renal Insufficiency, Chronic
1
Recurrence
1
Pulmonary Arterial Hypertension
1
Pseudomonas Infections
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pneumonia
1
Pancreatic Neoplasms
1
Interventions
Rocuronium
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
ziprasidone
1
venetoclax
1
saponin QA-21V1
1
perflutren
1
peginesatide
1
hematide
1
finerenone
1
empagliflozin
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Tobramycin
1
Thalidomide
1
Surveys and Questionnaires
1
Stem Cell Transplantation
1
Standard of Care
1
Spironolactone
1
Specimen Handling
1
Simethicone
1
Sevelamer
1
Resistance Training
1
Quillaja Saponins
1
Protein Subunit Vaccines
1
Practice Guidelines as Topic
1
Polymorphism, Genetic
1
Piperacillin, Tazobactam Drug Combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Renal Insufficiency, Chronic
×
Vancomycin
×
Clear all
NCT01431326
2023-09-06
PTN_POPS
Duke University
Completed
3,520 enrolled